Literature DB >> 20304804

Particle size and activation threshold: a new dimension of danger signaling.

Lorna Rettig1, Sebastian P Haen, Anne Greet Bittermann, Lotta von Boehmer, Alessandra Curioni, Stefanie D Krämer, Alexander Knuth, Steve Pascolo.   

Abstract

Previous studies have shown that single-stranded RNA (ssRNA) mixed with protamine forms particles and activates immune cells through Toll-like receptors (TLRs). We have found that the size of protamine-RNA particles generated depends on the electrolyte content when mixing the 2 components. Moreover, we have evidenced that (1) nanometric particles induce production of interferon-alpha, whereas (2) micrometric particles mainly induce production of tumor necrosis factor-alpha (TNF-alpha) in human immune cells. We found that the mechanisms underlying these observations are (1) nanoparticles but not microparticles are selectively phagocytosed by plasmacytoid dendritic cells (pDCs), which produce interferon-alpha and (2) monocytes that produce TNF-alpha have a higher activation threshold than that of pDCs. Thus, at the same time as sensing pathogen-associated molecular patterns such as ssRNA, the immune system distinguishes the size of the associated structure in such a way as to trigger the adapted antivirus (nanometric) or antibacterial/antifungal (micrometric) immune response. Our results introduce a new dimension in danger signaling--how size qualitatively affects innate response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20304804     DOI: 10.1182/blood-2009-11-247817

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  Time to cast a larger net.

Authors:  Matthew L Wheeler; David M Underhill
Journal:  Nat Immunol       Date:  2014-11       Impact factor: 25.606

Review 2.  Developing mRNA-vaccine technologies.

Authors:  Thomas Schlake; Andreas Thess; Mariola Fotin-Mleczek; Karl-Josef Kallen
Journal:  RNA Biol       Date:  2012-10-12       Impact factor: 4.652

Review 3.  Cytokines as biomarkers of nanoparticle immunotoxicity.

Authors:  Mahmoud Elsabahy; Karen L Wooley
Journal:  Chem Soc Rev       Date:  2013-06-21       Impact factor: 54.564

Review 4.  mRNA-based therapeutics--developing a new class of drugs.

Authors:  Ugur Sahin; Katalin Karikó; Özlem Türeci
Journal:  Nat Rev Drug Discov       Date:  2014-09-19       Impact factor: 84.694

Review 5.  Monocytes and macrophages in tissue repair: Implications for immunoregenerative biomaterial design.

Authors:  Molly E Ogle; Claire E Segar; Sraeyes Sridhar; Edward A Botchwey
Journal:  Exp Biol Med (Maywood)       Date:  2016-05

Review 6.  mRNA vaccines - a new era in vaccinology.

Authors:  Norbert Pardi; Michael J Hogan; Frederick W Porter; Drew Weissman
Journal:  Nat Rev Drug Discov       Date:  2018-01-12       Impact factor: 84.694

7.  A new role for microRNAs, as ligands of Toll-like receptors.

Authors:  Muller Fabbri; Alessio Paone; Federica Calore; Roberta Galli; Carlo M Croce
Journal:  RNA Biol       Date:  2013-01-07       Impact factor: 4.652

8.  Endosomal escape and siRNA delivery with cationic shell crosslinked knedel-like nanoparticles with tunable buffering capacities.

Authors:  Ritu Shrestha; Mahmoud Elsabahy; Stephanie Florez-Malaver; Sandani Samarajeewa; Karen L Wooley
Journal:  Biomaterials       Date:  2012-08-16       Impact factor: 12.479

Review 9.  Current understanding of interactions between nanoparticles and the immune system.

Authors:  Marina A Dobrovolskaia; Michael Shurin; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

10.  Exosome-delivered microRNAs promote IFN-α secretion by human plasmacytoid DCs via TLR7.

Authors:  Valentina Salvi; Veronica Gianello; Sara Busatto; Paolo Bergese; Laura Andreoli; Ugo D'Oro; Alessandra Zingoni; Angela Tincani; Silvano Sozzani; Daniela Bosisio
Journal:  JCI Insight       Date:  2018-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.